About us Pricing ContactSubscribe

J

Janis M. Taube

Johns Hopkins UniversityORCID https://orcid.org/0000-0002-8273-4395

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

New England Journal of Medicine201212,531 citations

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

New England Journal of Medicine20159,308 citations

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

Journal of Clinical Oncology20102,913 citations

Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

Nature reviews. Cancer20162,679 citations

Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy

Clinical Cancer Research20142,320 citationsFirst authorCorresponding

Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab

Journal of Clinical Oncology20142,198 citations

Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape

Science Translational Medicine20122,123 citationsFirst authorCorresponding

Alterations of immune response of non-small cell lung cancer with Azacytidine

Oncotarget2013386 citations

PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas

Human Pathology2015336 citations

Janis M. Taube · Scinovex